Tumour staging

Doctors will “stage” the disease once they have reviewed all the scans and results. This means an exact assessment is made as to how far the tumour has spread in the body. The different stages of neuroblastoma have different treatments, as they carry with them different risks. There are, however, other important factors which also affect the prognosis and these include:

  • the age of the child (children diagnosed under 18 months generally have less aggressive disease)
  • the appearance of the tumour cells under the microscope (histopathology)
  • the genetic makeup of the tumour cells – in particular a gene called “N-Myc” or “MycN”

After all the results, including the tumour biopsy, have been received the oncologist will classify the child’s neuroblastoma as low, intermediate or high risk and will provide details of the treatments required (often referred to as the ‘protocol’). It is important to note that if the tumour biopsy shows very aggressive disease (eg the gene called N-Myc is “amplified”) then staging becomes less relevant.

Amplified N-Myc means the tumour is very aggressive and high risk protocol will automatically be followed even if the tumour has not spread to other parts of the body.

For many years the International Neuroblastoma Staging System (INSS) has been used to assess individual children and these descriptions (stage 1, 2, 3, 4 and 4S) are likely to continue to run alongside a newer International Neuroblastoma Risk Group Staging System (INRSS). The new system is aimed at getting a better match between the risks and the side-effects of treatment with the risk of the disease. The approximate INRSS stage is shown in brackets against the INSS stage below:

  1. Stage 1 Neuroblastoma (INRSS stage L1)
  2. Stage 2 Neuroblastoma (INRSS stage L1)
  3. Stage 3 Neuroblastoma (INRSS stage L2)
  4. Stage 4 Neuroblastoma (INRSS stage M)
  5. Stage 4S (INRSS stage MS)
  6. Ganglioneuroblastoma

 

Stage 1 Neuroblastoma (INRSS stage L1)

The tumour is fairly small and confined to one site and it has not spread anywhere else in the body and it is able to be removed completely by an operation. This type of tumour is usually curable by surgery alone.

Stage 2 Neuroblastoma (INRSS stage L1)

As with stage 1, the tumour is confined to one site and has not spread to distant parts of the body. However it may be larger than a Stage 1 neuroblastoma and at operation, it may be more difficult to remove completely. Sometimes a lymph node or some glands near to the stage 2 neuroblastoma may also have been affected by the tumour. Stage 2 neuroblastoma may be treated with surgery alone or with chemotherapy.

Stage 3 Neuroblastoma (INRSS stage L2)

The tumour is also confined to the primary site and has not appeared in other distant parts of the body. The tumour may be very large and said to have crossed the ‘mid-line’ of the body. This means that the tumour has grown right across the child’s abdomen or chest from the original site where it began. In the case of stage 3 tumours, chemotherapy treatment will often be initially recommended to try and shrink the tumour for subsequent surgical removal. Further treatment will depend on the other tests described above.

Stage 4 Neuroblastoma (INRSS stage M)

This means that the primary tumour may be of any size but some neuroblastoma cells have broken away and spread to other organs of the body, most commonly bones, bone marrow or liver. Drug therapy (chemotherapy) will usually be recommended for a stage 4 neuroblastoma. This has 2 aims:

a)   to kill tumour cells that have spread to different body organs

b)   to shrink the primary tumour for later removal by an operation

After surgery, further drug therapy is given. Other treatment may then follow depending on the results of the tumour biopsy and how aggressive the neuroblastoma is.

Stage 4S (INRSS stage MS)

This is a special type of tumour found in very young babies, under one year old. The tumour cells may have spread beyond the “primary site” to other parts of the body but the cells usually behave in a less aggressive fashion than in older children. The tumour may even shrink and disappear without treatment. Alternatively, low doses of either radiotherapy or chemotherapy may be used.

Ganglioneuroblastoma

Ganglioneuroblastoma is another type of tumour, but a close relative of neuroblastoma. It can present in any age group but the cells of this tumour are more ‘mature’ (less likely to spread) than those of ordinary neuroblastoma.

Return to About Neuroblastoma

On 1st September, the sails of the Sydney Opera House will be lit in gold to mark the start of Childhood Cancer Awareness Month. There will be a candlelit vigil you can attend to honour all children diagnosed with cancer. For details see below. To show your support, you can also buy yellow wristbands: www.neuroblastoma.org.au/product-category/wristbands/ ...

September is International Childhood Cancer Awareness month. Join us at the Sydney Opera House on 1 September for a candlelight vigil and watch the Opera House sails turn gold & help raise awareness for childhood cancer research while honouring all children diagnosed with cancer. We are inviting all families & friends touched by childhood cancer to attend, or submit a photo for our digital tribute wall which will celebrate all kids affected by childhood cancer – past and present, and honour all the children who we couldn't find a cure for soon enough. To secure your place or provide a photo for the tribute wall, please email marketing@ccia.org.au Stay tuned for further posts with more information #gogoldforkids The Kids' Cancer Project Sydney Children's Hospital Foundation The Children's Hospital at Westmead

Neuroblastoma Australia
Ste 3, 165 Sailors Bay Rd
Northbridge NSW 2063
0406 991 606
info@nb.org.au
Neuroblastoma Australia Incorporated is a registered charity with GDR Status . ABN 74 173 375 414.